GlassScriptPhysician profile
Derek Carl Carlson
NPI 1790775450
$54,446.75
in general payments reported to CMS, 2019-2025
21 companies · $227 in 2025
The $227 reported for 2025 was more than what a typical Child & Adolescent Psychiatry provider received nationally (typical 2025 total: $132).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $5,760 · 2021: $13K · 2022: $8,797 · 2023: $427 · 2024: $450 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,104.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $32,467.17 | 2019-2023 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $12,967.31 | 2021-2025 | Qelbree, Qelbree |
| Corium, LLC | $8,090.38 | 2022 | |
| Lundbeck LLC | $154.23 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $116.15 | 2019-2020 | |
| Abbvie INC. | $99.60 | 2022-2024 | Vraylar |
| Otsuka America Pharmaceutical, INC. | $89.66 | 2019-2020 | |
| Alkermes, INC. | $70.20 | 2019-2020 | |
| Shire North American Group INC | $65.68 | 2019 | |
| Tris Pharma INC | $56.56 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $56.20 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $36.23 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $35.99 | 2019 | |
| Janssen Pharmaceuticals, INC | $30.27 | 2019 | |
| Neos Therapeutics, LP | $27.82 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $16.58 | 2020 | |
| Jazz Pharmaceuticals INC. | $14.96 | 2019 | |
| Almatica Pharma LLC | $14.45 | 2024 | Loreev Xr |
| Bausch Health US, LLC | $13.09 | 2019 | |
| Vertical Pharmaceuticals, LLC | $12.35 | 2019 | |
| Allergan, INC. | $11.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Carlson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.